Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 4:06 pm Purchase | 2024-09-30 | 13G | Alaunos Therapeutics, Inc. TCRT | MSD Partners L.P. | 101,010 6.300% | 101,010 (New Position) | Filing History |
| 2024-02-14 12:43 pm Purchase | 2023-12-31 | 13G | Alaunos Therapeutics, Inc. TCRT | DISCOVERY CAPITAL MANAGEMENT LLC | 400,186 1.660% | 292,279 (+270.86%) | Filing History |
| 2024-02-13 4:58 pm Purchase | 2023-12-31 | 13G | Alaunos Therapeutics, Inc. TCRT | MSD Partners L.P. | 2,272,727 9.200% | 2,272,727 (New Position) | Filing History |
| 2023-02-14 1:30 pm Unchanged | 2022-12-31 | 13G | Alaunos Therapeutics, Inc. TCRT | MSD Partners L.P. | 101,010 7.000% | 0 (Unchanged) | Filing History |
| 2023-02-14 1:18 pm Purchase | 2022-12-31 | 13G | Alaunos Therapeutics, Inc. TCRT | DISCOVERY CAPITAL MANAGEMENT LLC | 107,907 6.730% | 18,930 (+21.28%) | Filing History |
| 2023-02-09 10:54 am Sale | 2022-12-30 | 13G | Alaunos Therapeutics, Inc. TCRT | VANGUARD GROUP INC | 60,985 3.810% | -16,573 (-21.37%) | Filing History |
| 2023-01-20 09:02 am Sale | 2022-12-31 | 13G | Alaunos Therapeutics, Inc. TCRT | STATE STREET CORP STT | 5,214 0.330% | -83,578 (-94.13%) | Filing History |
| 2022-07-08 4:56 pm Sale | 2022-06-30 | 13G | Alaunos Therapeutics, Inc. TCRT | BlackRock Inc. BLK | 34,919 2.400% | -76,848 (-68.76%) | Filing History |
| 2022-02-14 5:06 pm Purchase | 2021-12-31 | 13G | Alaunos Therapeutics, Inc. TCRT | DISCOVERY CAPITAL MANAGEMENT LLC | 88,977 6.170% | 15,678 (+21.39%) | Filing History |
| 2022-02-11 2:57 pm Purchase | 2021-12-31 | 13G | Alaunos Therapeutics, Inc. TCRT | STATE STREET CORP STT | 88,792 6.160% | 88,792 (New Position) | Filing History |
| 2022-02-11 12:56 pm Sale | 2021-12-31 | 13G | Alaunos Therapeutics, Inc. TCRT | Hardie Robert D. | 68,446 4.800% | -1,682 (-2.40%) | Filing History |
| 2022-02-10 08:47 am Sale | 2021-12-31 | 13G | Alaunos Therapeutics, Inc. TCRT | VANGUARD GROUP INC | 77,558 5.380% | -28,905 (-27.15%) | Filing History |
| 2022-02-02 7:11 pm Sale | 2021-12-31 | 13G | Alaunos Therapeutics, Inc. TCRT | BlackRock Inc. BLK | 111,766 7.800% | -11,969 (-9.67%) | Filing History |
| 2021-10-12 1:40 pm Sale | 2021-09-30 | 13G | Alaunos Therapeutics, Inc. TCRT | MILLER VALUE PARTNERS LLC | 25,253 1.730% | -83,108 (-76.70%) | Filing History |
| 2021-02-16 1:10 pm Purchase | 2020-12-31 | 13G | Alaunos Therapeutics, Inc. TCRT | Hardie Robert D. | 70,128 4.900% | 1,254 (+1.82%) | Filing History |
| 2021-02-16 10:05 am Sale | 2020-12-31 | 13G | Alaunos Therapeutics, Inc. TCRT | MILLER VALUE PARTNERS LLC | 108,361 7.450% | -1,787 (-1.62%) | Filing History |
| 2021-02-10 12:04 pm Purchase | 2020-12-31 | 13G | Alaunos Therapeutics, Inc. TCRT | VANGUARD GROUP INC | 106,463 7.450% | 22,496 (+26.79%) | Filing History |
| 2021-02-01 08:23 am Purchase | 2020-12-31 | 13G | Alaunos Therapeutics, Inc. TCRT | BlackRock Inc. BLK | 123,736 8.700% | 40,457 (+48.58%) | Filing History |
| 2021-01-07 4:21 pm Purchase | 2020-12-28 | 13G | Alaunos Therapeutics, Inc. TCRT | DISCOVERY CAPITAL MANAGEMENT LLC | 73,298 5.130% | 73,298 (New Position) | Filing History |
| 2020-11-18 5:29 pm Sale | 2020-11-05 | 13G | Alaunos Therapeutics, Inc. TCRT | WHITE ROCK CAPITAL MANAGEMENT LP | 65,759 4.500% | -21,520 (-24.66%) | Filing History |